However, the role of CatB in cell survival and its basis of execution exhibit deep variance (Mijanović et al., 2019; Chevriaux et al., 2020); thus, a comprehensive analysis of CatB’s role in GBM is still unavailable, and in particular, no data are available regarding therapies with Pt(IV)-based drugs. The gene discussed is TYRP1; the disease is glioblastoma.